Answers are grounded in this paper and cite their sources.
Retrospective cohort study reveals that risk organ involvement and elevated metabolic PET/CT markers predict disease relapse in pediatric Langerhans cell histiocytosis, suggesting refined risk...
OBJECTIVE: To investigate the prognostic impact of risk organ involvement and baseline metabolic activity assessed by staging 18F-fluorodeoxyglucose (FDG) PET/computed tomography (CT) in newly diagnosed pediatric Langerhans cell histiocytosis (LCH). METHODS: Thirty-two children with histologically confirmed LCH who underwent baseline 18F-FDG PET/CT were retrospectively analyzed. Age, disease extent (single-system vs. multisystem), risk organ involvement (RO- vs. RO+), and baseline metabolic parameters [maximum standardized uptake value (SUVmax), SUVmean, metabolic tumor volume, total lesion glycolysis (TLG), and tumor-to-background ratio (TBR)] were evaluated for their association with progression or relapse. Optimal cut-offs were derived from receiver operating characteristic analysis (Youden index). Survival outcomes were analyzed using Kaplan-Meier and Cox regression models. RESULTS: Over a median follow-up of 33 months, disease progression or relapse occurred in 13 patients (40.6%) and was significantly associated with younger age (P = 0.040), higher SUVmax (P = 0.016), higher TBR (P = 0.007), and TLG (P = 0.033), multisystem LCH (P = 0.004), and risk organ positivity (P < 0.001). Risk-organ involvement was the strongest univariate predictor of adverse outcome (hazard ratio: 14.9, 95% confidence interval: 3.3-67; P < 0.001). CONCLUSION: Baseline 18F-FDG PET/CT provides important prognostic information in pediatric LCH, with risk organ involvement emerging as the strongest univariate prognostic factor in this cohort, supporting its role in early risk stratification, suggesting a potential role in future risk-adapted treatment planning. Higher SUVmax, TBR, and TLG were associated with progression/relapse in group comparisons, whereas only SUVmax and TBR were significantly associated with progression-free survival in univariate Cox analysis.
No takes yet. Share an insight, caveat, or question.
Öztürk et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: